Global rat model market worth USD 684.4 Million by 2021, growing at a CAGR of around 9.7% between 2016 and 2021.
The report analyzes and forecast rat model market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). Assessment of market dynamics gives a brief thought about the drivers and restraints for the rat model market along with their impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rat model market on a global level.
The report gives a transparent view on the rat model market. We have included a detailed competitive scenario and portfolio of leading vendors operative in rat model market. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the rat model market has also been included. The study encompasses a market attractiveness analysis, wherein rat type, technology, service, application and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a crucial view on the rat model by segmenting the market on the basis of types of rat, technology, services and application of the model. All the segments of rat model market have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Key rat type segments covered under this study includes outbred, conditioned, knockout and others. Key technology segments of the market covered under this study include embryonic stem cells, microinjection, and others. Breeding, Quarantine, Cryopreservation and others are the major services segment of rat model market. Application segment includes toxicology, CNS, oncology, immunology and inflammation, diabetes and others. The regional segmentation comprises the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa for rat model market.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global rat model market. The key player includes Covance, Inc., Transviragen Inc., SAGE Labs, Biomedical Research Models, Inc., genOway S.A., Transposagen Biopharmaceuticals, Harlan Laboratories, Inc and Charles River Laboratories amongst others.
The report segments of the global rat model market are as follows:
Rat Model Market: Rat Type Segment Analysis
Rat Model Market: Technology Segment Analysis
Rat Model Market: Service Segment Analysis
Rat Model Market: Application Segment Analysis
Rat Model Market: Regional Segment Analysis
This report is based on in-depth qualitative and quantitative analyses of the global Rat Model market. Zion Research has collected and analyzed key data belong to the global Rat Model market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Rat Model across the world has been calculated through primary and secondary research.
Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Rat Model industry. Primary research makes up major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Rat Model market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
The process of research with the help of rat to detect human mechanisms underlying human disease progress is called as rat model. The rat model is used by researcher due to the capability of rats to elucidate human disease processes. In addition, there is a lot of similarity between the genetics, physiology, and anatomy of rats and human. For hypertension and cardiovascular diseases, rat model is considered as an ideal model. Finger nucleases have enabled the generation of economically and technically feasible transgenic rat models.
The growth of rat model markets is primarily driven by continuous research practices undertaken to develop treatments for neurology disorders and cancer. In addition, the emergence of transgenic rat models coupled with advancement in bioinformatics which allow development of software and tools for analysis of data generated after pre-clinical research using rat models is anticipated to boost the growth of rat model in coming years. However, rising concern about animal cruelty coupled advancement in zebrafish models is expected to have the adverse impact on rat model market. Nonetheless, an initiative of government for investments and grants is likely to disclose new avenues for rat model market in the near future.
Outbred rat, conditioned rat, knockout rat and others rat are the type segments of rat model market. Outbred rat emerged as the largest segment in term of market share in 2015. This growth is attributed to extensive use of outbred rats in toxicology.
Service segment includes breeding, quarantine, cryopreservation and others. Breeding services acquired the largest market share in 2015 and expected to grow with highest CAGR during the forecast period. Cryopreservation service is expected to experience significant growth in coming years. Embryonic stem cells, microinjection, and others are the technology segment of rat model market.
Based on the various applications, the global rat model market is segmented into toxicology, oncology, CNS, immunology and inflammation, diabetes and other diseases segments. Oncology and toxicology segment are expected to experience significant growth in coming years as a consequence of rising incidences of different types of cancers.
Geographically, rat model market is dominated by North America followed by Europe. Government initiatives and funding for research activities are further expected to boost the market growth in these regions over the forecast period. Moreover, rat model market has a huge opportunity in the emerging markets of Asia Pacific due to increasing population.
The key player of this market includes Covance, Inc., Transviragen Inc ., SAGE Labs, Biomedical Research Models, Inc., genOway S.A., Transposagen Biopharmaceuticals, Harlan Laboratories, Inc and Charles River Laboratories amongst others.